ПЕРИТОНЕАЛЬНЫЙ КАНЦЕРОМАТОЗ
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Полный текст:
Аннотация
Рассматриваются основные патологические и морфогенетические аспекты развития перитонеального канцероматоза, рассмотрены молекулярно-биологические особенности, лежащие в основе этого процесса. Кроме того, представлены основные принципы классификации перитонеального канцероматоза и обозначены группы опухолей, которые могут осложняться диссеминацией по брюшине. Особое внимание уделено проблемам диагностики и лечения.
Об авторах
И. В. Степанов
Томский НИИ онкологии
ГБОУ ВПО «Сибирский государственный медицинский университет», г. Томск
Россия
634050, г. Томск, пер. Кооперативный, 5
Россия
634050, г. Томск, пер. Кооперативный, 5
Ю. М. Падеров
ГБОУ ВПО «Сибирский государственный медицинский университет», г. Томск
Россия
634050, г. Томск, пер. Кооперативный, 5
Россия
634050, г. Томск, пер. Кооперативный, 5
С. Г. Афанасьев
Томский НИИ онкологии
Россия
Россия
Список литературы
1. Abdullaev A.G., Polotskii B.E., Payanidi Yu.G., Zhordania K.I., Davydov M.I. Psevdomiksoma bryushiny // Onkoginekologiya. 2012. № 4. C. 25-34.
2. Afanas'ev S.G., Dobrodeev A.Yu. Tsitoreduktivnye operatsii (Nuzhno li udalyat' pervichnuyu opukhol'? Gde predel razumnoi tsitoreduktsii?) // Prakticheskaya onkologiya. 2014. T. 15, № 2. S. 93-100.
3. Davydov M.I., Ter-Ovanesov M.D., Buidenok Yu.V., Polotskii B.E., Gorbunova V.A., Abdullaev A.G. Gipertermicheskaya intraoperatsionnaya intraperitoneal'naya khimioterapiya pri rake zheludka: sushchestvuet li real'naya vozmozhnost' izmenit' prognoz? // Vestnik RONTs im. N.N. Blokhina RAMN. 2010. T. 21, № 1. S. 11-20.
4. Minimal'nye klinicheskie rekomendatsii Evropeiskogo obshchestva meditsinskoi onkologii (ESMO). M., 2010. S. 348-352.
5. Odishelidze N.V., Chistyakov S.S., Gabuniya Z.R. Znachenie diagnostiki subklinicheskoi intraperitoneal'noi disseminatsii u bol'nykh rakom zheludka // Rossiiskii meditsinskii zhurnal. Prilozhenie Onkologiya. 2011. T. 2. S. 49.
6. Petrovskaya N.A., Vozmitel' M.A., Khoruzhik S.A., Istomin Yu.P. Mul'timodal'noe lechenie peritoneal'nogo kantseromatoza v eksperimente // Onkologicheskii zhurnal. 2011. T. 5, № 4. S. 60-68.
7. Smirnova G.F., Kirichenko A.D., Fetisova T.I., Lopatin O.L., Verzhbitskaya N.E., Egorov A.A. Redkii sluchai disseminirovannogo peritoneal'nogo leiomiomatoza // Sibirskii onkologicheskii zhurnal. 2010. № 1. S. 85-87.
8. Shelepova V.M. Ispol'zovanie opukholevykh markerov dlya vyyavleniya lokalizatsii pervichnoi opukholi u patsientov s metastazami neizvestnogo proiskhozhdeniya // Rossiiskii bioterapevticheskii zhurnal. 2001. T. 1, № 3. S. 34-40.
9. Shpenkova A.A. Rak yaichnikov: Effektivnost' lecheniya v zavisimosti ot gradatsii kartsinomatoza, ili Nereshennye voprosy stadirovaniya // Vestnik Novgorodskogo gosudarstvennogo universiteta. 2010. № 59. S. 116-120.
10. Akiyama H., Yamaoka H., Tanaka K., Ishikawa T., Ichikawa Y., Wakasugi J., Nagashima Y., Shimada H. Continuous hyperthermic peritoneal perfusion for peritoneal dissemination of gastric cancer // Hepatogastroenterology. 1998. Vol. 45 (24). P. 2079-2086.
11. Bando E., Kawamura T., Kinoshita K., Takahashi S., Maeda A., Osada S., Tsubosa Y., Yamaguchi S., Uesaka K., Yonemura Y. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer // J. Am. Coll. Surg. 2003. Vol. 197 (2). P. 212-222.
12. Barnetson R.J., Burnett R.A., Downie I., Harper C.M., Roberts F. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful // Am. J. Clin. Pathol. 2006. Vol. 125 (1). P. 67-76.
13. Bozzetti F., Bonfanti G., Morabito A., Bufalino R., Menotti V., Andreola S., Doci R., Gennari L. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection // Surg. Gynecol. Obstet. 1986. Vol. 162 (3). P. 229-234.
14. Carr N.J., Emory T.S., Sobin L.H. Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apaptosis and expression of p53, CD44, bcl-2 // Arch. Pathol. Lab. Med. 2002. Vol. 126 (1). P. 837-841.
15. Ceelen W.P., Hesse U., Hemptinne V., Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intraabdominal cancer // Brit. J. Surg. 2000. Vol. 87. P. 1006-1015.
16. Costamagna D., Scuderi S., Vaira M., Barone R., De Simone M. Treatment of peritoneal mesothelioma using cytoreduction and intraperitoneal hyperthermic chemotherapy // Tumori. 2003. Vol. 89. P. 40-42.
17. Cotte E., Passot G., Gilly F.N., Glehen O. Selection of patients and staging of peritoneal surface malignancies // World J. Gastrointest. Oncol. 2010. Vol. 2 (1). P. 31-35. https://doi.org/10.4251/wjgo.v2.i1.31.
18. Deraco M., Santoro N., Carraro O., Inglese M.G., Rebuffoni G., Guadagni S., Somers D.C., Vaglini M. Peritoneal carcinomatosis: feature of dissemination. A review // Tumori. 1999. Vol. 85. P. 1-5.
19. Elias D., Glehen O., Pocard M., Quenet F., Goéré D., Arvieux C., Rat P., Gilly F. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix // Ann. Surg. 2010. Vol. 251 (5). P. 896-901. https://doi.org/10.1097/SLA.0b013e3181d9765d.
20. Faryammanesh R., Lange T., Magbanua E., Haas S., Meyer C., Wicklein D., Schumacher U., Hahn U. SDA, a DNA Aptamer Inhibiting E- and P-Selectin Mediated Adhesion of Cancer and Leukemia Cells, the First and Pivotal Step in Transendothelial Migration during Metastasis Formation // PLoS One. 2014. Vol. 9 (4). E. 93173. https://doi.org/10.1371/journal. pone.0093173.
21. Gebauer F., Wicklein D., Stübke K., Nehmann N., Schmidt A., Salamon J., Peldschus K., Nentwich M.F., Adam G., Tolstonog G., Bockhorn M., Izbicki J.R., Wagener C., Schumacher U. Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp-/rag2-mice // Gut. 2013. Vol. 62 (5). P. 741-750. https://doi.org/10.1136/gutjnl-2011-300629.
22. Glehen O., Gilly F.N., Boutitie F., Bereder J.M., Quenet F., Sideris L., Mansvelt B., Lorimier G., Msika S., Elias D. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients // Cancer. 2010. Vol. 116 (24). P. 5608-5618. https://doi.org/10.1002/cncr.25356.
23. Harmon R.L., Sugarbaker P.H. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer // Int. Semin. Surg. Oncol. 2005. Vol. 2 (1). P. 3.
24. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration // Nat. Rev. Cancer. 2002. Vol. 2. P. 91-100.
25. Jacquet P., Vidal-Jove J., Zhu B., Sugarbaker P. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management // Acta Chir. Belg. 1994. Vol. 94 (4). P. 191-197.
26. Japanese Classification of Gastric Carcinoma. 2nd English Edition Gastric Cancer // Gastric Cancer. 1998. Vol. 1. P. 10-24.
27. Kianmanesh R., Ruszniewski P., Rindi G., Kwekkeboom D., Pape U.F., Kulke M., Sevilla Garcia I., Scoazec J.Y., Nilsson O., Fazio N., Lesurtel M., Chen Y.J., Eriksson B., Cioppi F., O’Toole D. ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors // Neuroendocrinology. 2010. Vol. 91. P. 333-340. https://doi.org/10.1159/000286700.
28. Li G., Zhang Z., Ma X., Zhu J., Cai G. Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction // PLoS One. 2013. Vol. 8 (1). E. 54233. https://doi.org/10.1371/journal. pone.0054233.
29. Marhaba R., Zöller M. CD44 in cancer progression: adhesion, migration and growth regulation // J. Mol. Histol. 2004. Vol. 35. P. 211-231.
30. Nakanishi H., Kodera Y., Torii A., Hirai T., Yamamura Y., Kato T., Kito T., Tatematsu M. Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction // Jpn. J. Cancer Res. 1997. Vol. 7. P. 687-692.
31. Nomura E., Niki M., Fujii K., Shinohara H., Nishiguchi K., Sonoda T., Tanigawa N. Efficacy of intraperitoneal and intravenous chemo- therapy and left upper abdomen evisceration for advanced gastric cancer // Gastric Cancer. 2001. Vol. 4. P. 75-82.
32. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? // Nat. Rev. Cancer. 2007. Vol. 7 (6). P. 415-428.
33. Perrot G., Langlois B., Devy J., Jeanne A., Verzeaux L., Almagro S., Sartelet H., Hachet C., Schneider C., Sick E., David M., Khrestchatisky M., Emonard H., Martiny L., Dedieu S. LRP-1-CD44, a new cell surface complex regulating tumor cell adhesion // Mol. Cell. Biol. 2012. Vol. 32. P. 3293-3307. https://doi.org/10.1128/MCB.00228-12.
34. Rivard J.D., McConnell Y.J., Temple W.J., Mack L.A. Cytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: are we excluding patients who may benefit? // J. Surg. Oncol. 2014. Vol. 109 (2). P. 104-109. https://doi.org/10.1002/jso.23446.
35. Scaringi S., Kianmanesh R., Sabate J.M., Facchiano E., Jouet P., Coffin B., Parmentier G., Hay J.M., Flamant Y., Msika S. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intra-peritoneal-chemotherapy: A single western center experience // Eur. J. Surg. Oncol. 2008. Vol. 34 (11). P. 1246-1252. https://doi.org/10.1016/j. ejso.2007.12.003.
36. Serafino A., Zonfrillo M., Andreola F., Psaila R., Mercuri L., Moroni N., Renier D., Campisi M., Secchieri C., Pierimarchi P. CD44- targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis // Curr. Cancer Drug. Targets. 2011. Vol. 11 (5). P. 572-585.
37. Spiliotis J.D., Halkia E.A., Efstathiou E. Peritoneal carcinomatosis 2011; it’s about time for chemosurgery // J. BUON. 2011. Vol. 16 (3). P. 400-408.
38. Sugarbaker P.H. Cytoreduction including total gastrectomy for pseudomyxoma peritonei // Brit. J. Surg. 2002. Vol. 89. P. 208-212.
39. Sugarbaker P.H. Overview of peritoneal carcinomatosis // Cancerologia. 2008. Vol. 3. P. 119-124.
40. Sugarbaker P.H. Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy // Tech. Coloproctol. 2005. Vol. 9 (2). P. 95-103.
41. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression // Nat. Rev. Cancer. 2002. Vol. 2. P. 442-454.
42. Votanopoulos K.I., Swett K., Blackham A.U., Ihemelandu C., Shen P., Stewart J.H., Levine E.A. Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis from Rectal Cancer // Ann. Surg. Oncol. 2013. Vol. 20 (4). P. 1088-1092. https://doi.org/10.1245/ s10434-012-2787-3.
43. Wagner B.J., Löb S., Lindau D., Hörzer H., Gückel B., Klein G., Glatzle J., Rammensee H.G., Brücher B.L., Königsrainer A. Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and 1 integrin // Int. J. Oncol. 2011. Vol. 39. P. 1593-1600. https://doi.org/10.3892/ijo.2011.1167.
44. Yang X.J., Li Y., al-shammaa Hassan A.H., Yang G.L., Liu S.Y., Lu Y.L., Zhang J.W., Yonemura Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases // Ann. Surg. Oncol. 2009. Vol. 16 (2). P. 345-351. https://doi.org/10.1245/s10434-008-0226-2.
Рецензия
Для цитирования:
Степанов И.В., Падеров Ю.М., Афанасьев С.Г. ПЕРИТОНЕАЛЬНЫЙ КАНЦЕРОМАТОЗ. Сибирский онкологический журнал. 2014;(5):45-53.
For citation:
Stepanov I.V., Paderov Yu.М., Afanasyev S.G. PERITONEAL CARCINOMATOSIS. Siberian journal of oncology. 2014;(5):45-53. (In Russ.)
Просмотров:
1927
ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)
ISSN 2312-3168 (Online)
Послать статью по эл. почте 
